Before Invest
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON

JNJ
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 28, 2026
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance Sheet
Period
Annual Quarterly
Order
Unlock 40 quarters
Format
% Change
Rows
USD ($)
$ in Millions 		Jun 28, 2026Mar 29, 2026Sep 28, 2025Jun 29, 2025Mar 30, 2025Sep 29, 2024Jun 30, 2024Mar 31, 2024Oct 1, 2023Jul 2, 2023Apr 2, 2023Oct 2, 2022Jul 3, 2022Apr 3, 2022Oct 3, 2021Jul 4, 2021Apr 4, 2021Sep 27, 2020Jun 28, 2020Mar 29, 2020Sep 29, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jul 1, 2018Apr 1, 2018Oct 1, 2017Jul 2, 2017Apr 2, 2017Oct 2, 2016Jul 3, 2016Apr 3, 2016Sep 27, 2015Jun 28, 2015Mar 29, 2015Sep 28, 2014Jun 29, 2014Mar 30, 2014Sep 29, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jul 1, 2012Apr 1, 2012Oct 2, 2011Jul 3, 2011Apr 3, 2011Oct 3, 2010Jul 4, 2010Apr 4, 2010Sep 27, 2009Jun 28, 2009
Current assets:
                                                    
Cash and cash equivalents (Note 4)
$ 20,422
$ 21,688
$ 18,231
$ 18,577
$ 38,474
$ 19,980
$ 24,878
$ 25,473
$ 19,728
$ 21,183
$ 19,170
$ 11,355
Restricted cash (Note 4)
-
-
-
-
-
-
-
-
-
-
7,695
-
Marketable securities
336
363
331
303
307
317
597
745
3,783
7,322
5,443
22,724
Accounts receivable, trade, less allowances $171 (2025, $183)
19,046
17,721
17,611
17,846
16,020
16,174
15,794
14,946
14,798
16,777
16,350
15,890
Inventories (Note 2)
15,144
14,583
14,146
13,412
12,659
12,603
12,169
11,383
11,198
12,888
12,809
11,675
Deferred taxes on income
-
-
-
-
-
-
-
-
-
-
-
-
Prepaid expenses and other
4,826
4,818
4,292
4,360
4,091
4,175
4,379
4,455
4,196
2,397
2,921
3,592
Current assets of discontinued operations (Note 12)
-
-
-
-
-
-
-
-
0
-
-
-
Assets held for sale (Note 10)
-
-
-
-
-
-
-
-
-
-
-
-
Total current assets
59,774
59,173
54,611
54,498
71,551
53,249
57,817
57,002
53,703
60,567
64,388
65,236
Marketable securities, non-current
-
-
-
-
-
-
-
-
-
-
-
-
Property, plant and equipment at cost
55,518
54,695
53,375
52,472
49,884
49,274
48,035
47,585
45,626
51,218
50,367
46,681
Less: accumulated depreciation
31,936
31,425
31,037
30,523
29,013
28,795
28,287
27,953
26,805
30,642
30,193
28,529
Property, plant and equipment, net
23,582
23,270
22,338
21,949
20,871
20,479
19,748
19,632
18,821
20,576
20,174
18,152
Intangible assets, net (Note 3)
48,229
49,061
48,737
49,835
36,755
39,490
39,725
34,286
35,021
46,246
47,448
40,336
Goodwill (Note 3)
48,479
48,558
48,048
48,117
44,468
44,799
44,250
36,616
36,124
45,440
45,575
33,383
Deferred taxes on income (Note 5)
6,728
6,727
6,666
6,801
8,492
9,349
9,004
10,305
9,259
8,779
8,817
9,392
Other assets
14,269
14,105
12,416
12,189
11,534
10,921
10,544
14,125
13,133
10,078
9,567
8,625
Noncurrent assets of discontinued operations (Note 12)
-
-
-
-
-
-
-
-
0
-
-
-
Total assets
201,061
200,894
192,816
193,389
193,671
178,287
181,088
171,966
166,061
191,686
195,969
175,124
Liabilities and shareholders’ equity
                                                    
Current liabilities:
                                                    
Loans and notes payable
11,692
17,460
6,387
11,526
13,897
4,462
9,855
8,550
3,870
11,701
17,979
4,424
Accounts payable
9,223
10,460
9,625
9,464
9,545
8,954
8,848
8,174
8,355
10,443
9,909
10,153
Accrued liabilities
9,464
7,399
7,601
7,404
7,913
11,450
10,539
10,323
10,101
10,605
11,204
11,953
Accrued rebates, returns and promotions
19,990
18,399
21,356
20,823
18,780
18,439
17,539
16,182
15,808
15,672
14,784
14,021
Accrued compensation and employee related obligations
3,475
2,911
3,972
3,298
2,551
3,620
2,843
2,178
3,337
3,062
2,231
3,006
Accrued taxes on income (Note 5)
1,051
1,087
1,928
1,665
4,217
4,834
4,309
3,318
2,899
2,687
4,266
1,986
Current liabilities of discontinued operations (Note 12)
-
-
-
-
-
-
-
-
0
-
-
-
Total current liabilities
54,895
57,716
50,869
54,180
56,903
51,759
53,933
48,725
44,370
54,170
60,373
45,543
Long-term debt (Note 4)
37,344
37,527
39,408
39,235
38,355
31,289
31,636
25,082
26,051
33,901
34,928
27,603
Deferred taxes on income (Note 5)
6,608
7,011
5,988
3,799
2,428
2,952
2,635
3,172
2,623
3,627
4,417
4,946
Employee related obligations (Note 6)
6,657
6,760
6,930
7,021
7,046
6,852
6,919
7,019
5,687
6,461
6,665
8,353
Long-term taxes payable (Note 5)
485
486
418
418
395
354
341
2,881
2,540
2,536
4,296
4,162
Other liabilities
10,101
10,208
9,926
10,263
10,435
14,923
14,086
15,067
13,562
14,582
14,421
9,918
Noncurrent liabilities of discontinued operations (Note 12)
-
-
-
-
-
-
-
-
0
-
-
-
Total liabilities
116,090
119,708
113,539
114,916
115,562
108,129
109,550
101,946
94,833
115,277
125,100
100,525
Shareholders’ equity:
                                                    
Common stock — par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)
3,120
3,120
3,120
3,120
3,120
3,120
3,120
3,120
3,120
3,120
3,120
3,120
Accumulated other comprehensive income (loss) (Note 7)
(13,951)
(14,831)
(15,237)
(14,305)
(11,740)
(12,522)
(11,253)
(10,768)
(8,780)
(13,135)
(12,626)
(15,292)
Retained earnings and Additional paid-in capital
171,665
169,161
167,281
165,371
162,635
155,179
155,360
153,378
152,536
129,381
124,558
127,917
Less: common stock held in treasury, at cost (711,615,000 and 711,904,000 shares)
75,863
76,264
75,887
75,713
75,906
75,619
75,689
75,710
75,648
44,217
44,183
41,146
Total shareholders’ equity
84,971
81,186
79,277
78,473
78,109
70,158
71,538
70,020
71,228
75,149
-
-
Total shareholders’ equity
84,971
81,186
79,277
78,473
78,109
70,158
71,538
70,020
71,228
76,409
70,869
74,599
Stockholders' Equity Attributable to Noncontrolling Interest
-
-
-
-
-
-
-
-
-
1,260
-
-
Total liabilities and shareholders’ equity
$ 201,061
$ 200,894
$ 192,816
$ 193,389
$ 193,671
$ 178,287
$ 181,088
$ 171,966
$ 166,061
$ 191,686
$ 195,969
$ 175,124
Common Stock, Par or Stated Value Per Share
-
-
-
-
-
-
-
-
-
-
-
-
Common Stock, Shares Authorized
-
-
-
-
-
-
-
-
-
-
-
-
Common Stock, Shares, Issued
-
-
-
-
-
-
-
-
-
-
-
-